Nicolas G, Charbonnier C, Campion D. From common to rare variants: the genetic component of Alzheimer disease. Hum Hered. 2016;81(3):129–41.
Nicolas G, Zarea A, Lacour M, et al. Assessment of Mendelian and risk-factor genes in Alzheimer disease: a prospective nationwide clinical utility study and recommendations for genetic screening. Genet Med. 2024;26(5): 101082.
Jia L, Fu Y, Shen L, et al. PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer’s disease. Alzheimers Dement. 2020;16(1):178–91.
Nan H, Kim YJ, Chu M, et al. Genetic and clinical landscape of Chinese frontotemporal dementia: dominance of TBK1 and OPTN mutations. Alzheimers Res Ther. 2024;16(1): 127.
PubMed PubMed Central Google Scholar
Xu T, Weng L, Zhang C, et al. Genetic spectrum features and diagnostic accuracy of four plasma biomarkers in 248 Chinese patients with frontotemporal dementia. Alzheimers Dement. 2024;20(10):7281–95.
PubMed PubMed Central Google Scholar
Fouillade C, Chabriat H, Riant F, et al. Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain. Hum Mutat. 2008;29(3):452.
Guo L, Jiao B, Liao X, et al. The role of NOTCH3 variants in Alzheimer’s disease and subcortical vascular dementia in the Chinese population. CNS Neurosci Ther. 2021;27(8):930–40.
PubMed PubMed Central Google Scholar
Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383(6602):707–10.
Rutten JW, Haan J, Terwindt GM, van Duinen SG, Boon EM, Lesnik Oberstein SA. Interpretation of NOTCH3 mutations in the diagnosis of CADASIL. Expert Rev Mol Diagn. 2014;14(5):593–603.
Joutel A, Vahedi K, Corpechot C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350(9090):1511–5.
Muino E, Gallego-Fabrega C, Cullell N, et al. Systematic review of cysteine-sparing NOTCH3 missense mutations in patients with clinical suspicion of CADASIL. Int J Mol Sci. 2017. https://doi.org/10.3390/ijms18091964.
Rutten JW, Hack RJ, Duering M, et al. Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank: CADASIL to nonpenetrance. Neurology. 2020;95(13):e1835–43.
PubMed PubMed Central Google Scholar
Goldman JS, Farmer JM, Wood EM, et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 2005;65(11):1817–9.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.
PubMed PubMed Central Google Scholar
Owen F, Poulter M, Collinge J, et al. Insertions in the prion protein gene in atypical dementias. Exp Neurol. 1991;112(2):240–2.
DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245–56.
PubMed PubMed Central Google Scholar
McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263–9.
Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546–54.
Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456–77.
PubMed PubMed Central Google Scholar
Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006–14.
PubMed PubMed Central Google Scholar
Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293–9.
Park HK, Chung SJ. New perspective on parkinsonism in frontotemporal lobar degeneration. J Mov Disord. 2013;6(1):1–8.
PubMed PubMed Central Google Scholar
Nan H, Chu M, Jiang D, et al. Identification and characterization of variants in PSEN1, PSEN2, and APP genes in Chinese patients with early-onset Alzheimer’s disease. Alzheimers Res Ther. 2025;17(1): 54.
PubMed PubMed Central Google Scholar
Duering M, Karpinska A, Rosner S, et al. Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysis. Hum Mol Genet. 2011;20(16):3256–65.
Sanchez-Irizarry C, Carpenter AC, Weng AP, Pear WS, Aster JC, Blacklow SC. Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. Mol Cell Biol. 2004;24(21):9265–73.
PubMed PubMed Central Google Scholar
Rutten JW, Dauwerse HG, Gravesteijn G, et al. Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL. Ann Clin Transl Neurol. 2016;3(11):844–53.
PubMed PubMed Central Google Scholar
Rutten JW, Van Eijsden BJ, Duering M, et al. The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1–6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7–34 pathogenic variant. Genet Med. 2019;21(3):676–82.
Mukai M, Mizuta I, Watanabe-Hosomi A, et al. Genotype-phenotype correlations and effect of mutation location in Japanese CADASIL patients. J Hum Genet. 2020;65(8):637–46.
He R, Li H, Sun Y, et al. Homozygous NOTCH3 p. R587C mutation in Chinese patients with CADASIL: a case report. BMC Neurol. 2020;20(1): 72.
PubMed PubMed Central Google Scholar
Chen S, Ni W, Yin XZ, et al. Clinical features and mutation spectrum in Chinese patients with CADASIL: a multicenter retrospective study. CNS Neurosci Ther. 2017;23(9):707–16.
PubMed PubMed Central Google Scholar
You J, Liao S, Zhang F, Ma Z, Li G. First report of Arg587Cys mutation of Notch3 gene in two Chinese families with CADASIL. J Stroke Cerebrovasc Dis. 2017;26(1):e1–4.
Liao YC, Hsiao CT, Fuh JL, et al. Characterization of CADASIL among the Han Chinese in Taiwan: distinct genotypic and phenotypic profiles. PLoS ONE. 2015;10(8): e0136501.
PubMed PubMed Central Google Scholar
Kilarski LL, Rutten-Jacobs LC, Bevan S, et al. Prevalence of CADASIL and Fabry disease in a cohort of MRI defined younger onset lacunar stroke. PLoS ONE. 2015;10(8): e0136352.
PubMed PubMed Central Google Scholar
Kim Y, Choi EJ, Choi CG, et al. Characteristics of CADASIL in Korea: a novel cysteine-sparing Notch3 mutation. Neurology. 2006;66(10):1511–6.
Yoon CW, Kim YE, Seo SW, et al. NOTCH3 variants in patients with subcortical vascular cognitive impairment: a comparison with typical CADASIL patients. Neurobiol Aging. 2015;36(8):2443 e2441–2447.
Kim Y, Lee SH. Novel characteristics of race-specific genetic functions in Korean CADASIL. Medicina (Kaunas). 2019. https://doi.org/10.3390/medicina55090521.
Wang J, Li J, Kong F, Lv H, Guo Z. Bipolar II disorder as the initial presentation of CADASIL: an underdiagnosed manifestation. Neuropsychiatr Dis Treat. 2017;13:2175–9.
PubMed PubMed Central Google Scholar
Ni W, Zhang Y, Zhang L, Xie JJ, Li HF, Wu ZY. Genetic spectrum of NOTCH3 and clinical phenotype of CADASIL patients in different populations. CNS Neurosci Ther. 2022;28(11):1779–89.
PubMed PubMed Central Google Scholar
Koriath C, Kenny J, Adamson G, et al. Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series. Mol Psychiatry. 2020;25(12):3399–412.
Wang G, Zhang DF, Jiang HY, et al. Mutation and association analyses of dementia-causal genes in Han Chinese patients with early-onset and familial Alzheimer’s disease. J Psychiatr Res. 2019;113:141–7.
Bianchi S, Zicari E, Carluccio A, et al. CADASIL in central Italy: a retrospective clinical and genetic study in 229 patients. J Neurol. 2015;262(1):134–41.
Craggs LJ, Yamamoto Y, Ihara M, et al. White matter pathology and disconnection in the frontal lobe in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Neuropathol Appl Neurobiol. 2014;40(5):591–602.
Ross OA, Soto-Ortolaza AI, Heckman MG, et al. NOTCH3 variants and risk of ischemic stroke. PLoS ONE. 2013;8(9): e75035.
PubMed PubMed Central Google Scholar
Yamamoto Y, Ihara M, Tham C, et al. Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. Stroke. 2009;40(6):2004–11.
Comments (0)